A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
Clinical trial NCT03571256 · COMPLETED
Trial details
- NCT number
- NCT03571256
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2019-12-09
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.